AIP
STOK icon

Ameritas Investment Partners’s Stoke Therapeutics STOK Stock Holding History

Ameritas Investment Partners’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131K Buy
4,009
+261
+7% +$8.56K ﹤0.01% 1527
2025
Q4 		$119K Hold
3,748
– – ﹤0.01% 1598
2025
Q3 		$88.1K Sell
3,748
-436
-10% -$7.47K ﹤0.01% 1758
2025
Q2 		$47.5K Buy
4,184
+700
+20% +$6.65K ﹤0.01% 2218
2025
Q1 		$23.2K Hold
3,484
– – ﹤0.01% 2487
2024
Q4 		$38.4K Hold
3,484
– – ﹤0.01% 2341
2024
Q3 		$42.8K Hold
3,484
– – ﹤0.01% 2280
2024
Q2 		$47.1K Buy
3,484
+1,206
+53% +$16.3K ﹤0.01% 2170
2024
Q1 		$30.8K Hold
2,278
– – ﹤0.01% 2393
2023
Q4 		$12K Hold
2,278
– – ﹤0.01% 2786
2023
Q3 		$8.97K Hold
2,278
– – ﹤0.01% 2866
2023
Q2 		$24.2K Buy
2,278
+781
+52% +$8.31K ﹤0.01% 2467
2023
Q1 		$12.5K Hold
1,497
– – ﹤0.01% 2642
2022
Q4 		$13.9K Hold
1,497
– – ﹤0.01% 2703
2022
Q3 		$19K Hold
1,497
– – ﹤0.01% 2556
2022
Q2 		$19K Hold
1,497
– – ﹤0.01% 2573
2022
Q1 		$32K Hold
1,497
– – ﹤0.01% 2331
2021
Q4 		$36K Hold
1,497
– – ﹤0.01% 2338
2021
Q3 		$38K Hold
1,497
– – ﹤0.01% 2344
2021
Q2 		$50K Buy
1,497
+418
+39% +$14.8K ﹤0.01% 2187
2021
Q1 		$42K Hold
1,079
– – ﹤0.01% 2190
2020
Q4 		$67K Hold
1,079
– – ﹤0.01% 1813
2020
Q3 		$36K Hold
1,079
– – ﹤0.01% 2040
2020
Q2 		$26K Sell
1,079
-401
-27% -$9.52K ﹤0.01% 2219
2020
Q1 		$34K Buy
1,480
+719
+94% +$17.8K ﹤0.01% 1879
2019
Q4 		$22K Hold
761
– – ﹤0.01% 2372
2019
Q3 		$16K Buy
+761
New +$21.2K ﹤0.01% 2519

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Ameritas Investment Partners's STOK Position: Q1 2026 in Review

Ameritas Investment Partners increased its Stoke Therapeutics (STOK) stake by 7% in Q1 2026, buying an estimated $8.56K and bringing the position to 4,009 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Ameritas Investment Partners first reported a position in STOK in Q3 2019 and has held it in 27 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Ameritas Investment Partners held 4,009 shares of Stoke Therapeutics worth $131K as of Q1 2026.
  • Ameritas Investment Partners bought 261 Stoke Therapeutics shares in Q1 2026, an estimated $8.56K.
  • Stoke Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1527 holding.
  • Ameritas Investment Partners first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 27 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.